TopNews New ZealandHeart Failure Drug Promising in Phase III TrialMedPage TodayA novel agent for treating acute heart failure met one of its two primary endpoints in reducing dyspnea, but which one has not yet been divulged, according to a statement fr…
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the pr…
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection – News-Medical.net
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejectionNews-Medical.netAstellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced it has submitted a Ne…
Ceva Sante Animale launches heart failure therapy for dogs – Zenopa
Ceva Sante Animale launches heart failure therapy for dogsZenopaCeva Sante Animale has launched Cardalis, a canine heart failure treatment that combines two proven active ingredients. The unique therapy combines benazepril and spironolactone into a sin…
Omega-3s again linked to lower heart failure risk – NutraIngredients-usa.com
NutraIngredients-usa.comOmega-3s again linked to lower heart failure riskNutraIngredients-usa.comData from over 20,000 people indicated that higher blood levels of ALA (alpha-linolenic acid) had a 34% lower risk, compared with people with lower levels,…
Shock tactic to raise heart failure awareness – Hartlepool Mail
Hartlepool MailShock tactic to raise heart failure awarenessHartlepool MailNew figures from the British Heart Foundation reveal a total of 746 people in the Hartlepool PCT area are currently living with heart failure, a condition most commonly caused b…
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release Capsules, a Prophylaxis of Organ Rejection …
NORTHBROOK, Ill., Sept. 24, 2012 /PRNewswire/ — Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced it has submitted a …
Kidney Transplant Waiting List Faces Revisions
The United Network for Organ Sharing (UNOS) has proposed a new scheme for distributing deceased-donor kidneys among the 93,000 people currently waiting for a transplant. UNOS handles organ procurement and transplantation pursuant to a contract with the…
Peregrine Pharma Stock Crater on Lung Cancer Drug Blowup – TheStreet.com
Peregrine Pharma Stock Crater on Lung Cancer Drug BlowupTheStreet.comBut Peregrine conducted half the study in India and Eastern Europe — geographies with bad reputations for producing overly positive results that cannot be reproduced in larger, confi…
Man's failing heart heals itself before transplant
Michael Crowe, 23, was in desperate need of a heart transplant when the incredible happened: His heart healed itself